AGP Wire
Stay informed with articles highlighting the latest developments, major events, and essential updates.
ADA-SCID market seen reaching $8.11 billion by 2030
AGP
The Business Research Company says the adenosine deaminase-severe combined immunodeficiency market will rise from $6.33 billion in 2026 to $8.11 billion by 2030. Growth is expected to be driven by more gene therapy, enzyme replacement and stem…
Adipose tissue stem cell market seen reaching $2.14 billion by 2030
AGP
The global adipose tissue derived stem cell market is forecast to grow from $1.35 billion in 2026 to $2.14 billion by 2030, driven by regenerative medicine, cell-therapy commercialization and broader clinical use. North America led the market in…
Afluria vaccine market seen growing on flu demand and aging population
AGP
The Business Research Company says the Afluria vaccine market is set to expand through 2035, driven by seasonal flu outbreaks, broader vaccination coverage and a growing older population.
Afrezza market outlook brightens on rising diabetes demand
AGP
The Business Research Company says the global Afrezza market is set for stronger growth through 2035 as diabetes cases rise, healthcare spending increases and inhaled insulin gains wider acceptance.
Adlyxin market forecast points to faster growth in Asia-Pacific
AGP
The Business Research Company says the global Adlyxin (Lyxumia) market is expanding as type 2 diabetes and obesity rates rise, with North America leading in 2025 and Asia-Pacific set for the fastest growth through 2035. The report also highlights…
Acute spinal cord injury market seen reaching $9.4 billion by 2030
AGP
The acute spinal cord injury market is projected to grow from $7.43 billion in 2026 to $9.4 billion by 2030, according to The Business Research Company.
Adcetris market seen growing to $2.12 million by 2030
AGP
The Business Research Company says the global Adcetris market is expanding on rising cancer cases, demand for targeted therapies and broader use in oncology.
King Dr. Ruben Maurice West wins Pan African Global Lifetime Icon Award
AGP
HRH King Dr. Ruben Maurice West received the Pan African Global Lifetime Icon Award at a gathering of international dignitaries recognizing his humanitarian service, diplomacy and leadership across Africa.
ARDS market seen reaching $2.42 billion by 2030
AGP
The acute respiratory distress syndrome market is forecast to grow from $1.41 billion in 2025 to $2.42 billion by 2030, driven by rising respiratory illness, ICU expansion and advances in ventilation and ECMO. North America held the largest market…
Advate market forecast points to stronger demand through 2035
AGP
The Business Research Company says the Advate market will keep expanding through 2035, driven by rising hemophilia A diagnoses, broader use of prophylactic therapy, and growing preference for home-based care.
Adbry/Adtralza market seen growing through 2030 on eczema demand
AGP
The Business Research Company says the global Adbry/Adtralza market has growth potential through 2030, driven by rising atopic dermatitis cases, broader biologic use and improving reimbursement.
ADZYNMA market study sees rare-disease demand and regional growth ahead
AGP
The Business Research Company says the global ADZYNMA market is set for a new growth phase through 2035, driven by rare-disease awareness, genetic screening and broader access to targeted therapies.
Aduhelm market report points to aging-driven demand and faster Asia-Pacific growth
AGP
The Business Research Company says the Aduhelm market is expanding as Alzheimer’s cases rise, diagnosis improves and demand grows for disease-modifying therapies.
Acute pharyngitis market seen reaching $4.25 billion by 2030
AGP
The acute pharyngitis market is projected to rise from $2.89 billion in 2025 to $3.13 billion in 2026, with The Business Research Company forecasting $4.25 billion by 2030. Rising influenza and respiratory infections, along with telemedicine and…
Addiction rehab facilities market seen climbing to $33.1 billion by 2030
AGP
The Business Research Company says the global addiction rehab facilities market is growing on rising substance use disorder rates, better insurance coverage and expanding treatment options.
Addison's disease market seen reaching $3.53 billion by 2030
AGP
The Business Research Company projects the global Addison’s disease market will grow from $2.46 billion in 2026 to $3.53 billion by 2030. The report points to rising autoimmune disease rates, broader diagnostic access and newer treatment…
ADME toxicology testing market to reach $20.25 billion by 2030
AGP
The ADME toxicology testing market is projected to grow from $11.5 billion in 2025 to $20.25 billion by 2030, driven by rising drug development activity, tighter safety rules and broader use of advanced testing tools.
ARF market seen reaching $9.71 billion by 2030
AGP
The acute renal failure market is projected to grow from $6.6 billion in 2025 to $9.71 billion by 2030, driven by higher rates of diabetes, hypertension and chronic kidney disease.
Adagen market seen growing to $0.13 million by 2030
AGP
The Business Research Company says the global Adagen market is set for steady growth, rising from $0.09 million in 2025 to $0.1 million in 2026 and reaching $0.13 million by 2030. The report points to rising precision medicine use, more rare…
Addictions therapeutics market seen reaching $10.24 billion by 2030
AGP
The addictions therapeutics market is projected to grow from $7.46 billion in 2025 to $7.93 billion in 2026, with North America holding the largest regional share.
Sign up for:
Africa News Currents
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.